Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Copanlisib and Nivolumab in MSS Colorectal Cancer
NCT03711058Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Jan 2019
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of copanlisib in colorectal cancer (CRC), solid tumor, sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Jan 2019; status: completed.
02
Drugs
copanlisib
03
Conditions
colorectal cancer (CRC)solid tumor
Beyond the preview
Go deeper on NCT03711058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03711058.